Liying Ma

Liying Ma


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SCShuihong Cheng
Shuihong Cheng
YWYan Wang
Yan Wang
ZZZhenxing Zhang
Zhenxing Zhang
XLXun Lv
Xun Lv
GGGeorge F. Gao
George F. Gao
XLXuebing Li
Xuebing Li

27 January 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XWXiaowei Wang
Xiaowei Wang
JZJianfang Zhang
Jianfang Zhang
YHYang Huang
Yang Huang
RWRuiping Wang
Ruiping Wang
LZLiang Zhang
Liang Zhang
JLJunyi Liu
Junyi Liu

18 April 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ALAmin Li
Amin Li
YOYabo Ouyang
Yabo Ouyang
ZWZiyun Wang
Ziyun Wang
YCYuanyuan Cao
Yuanyuan Cao
XLXiangyi Liu
Xiangyi Liu
JLJunyi Liu
Junyi Liu

2 September 2019 in Viruses
Verified
Journal Article
Open access
PDF file
CWChen Wang
Chen Wang
SCShuihong Cheng
Shuihong Cheng
YZYuanyuan Zhang
Yuanyuan Zhang
YDYibo Ding
Yibo Ding
HCHuihui Chong
Huihui Chong
LMLiying Ma
Liying Ma
The clinical application of HIV fusion inhibitor, enfuvirtide (T20), was limited mainly because of its short half-life. Here we designed and synthesized two PEGylated C34 peptides, PEG2kC34 and PEG5kC34, with the PEG chain length of 2 and 5 kDa, respectively, and evaluated their anti-HIV-1 activity and mechanisms of action. We found that these two PEGylated peptides could bind to the HIV-1 peptide N36 to form high affinity complexes with high α-helicity. The peptides PEG2kC34 and PEG5kC34 effectively inhibited HIV-1 Env-mediated cell–cell fusion with an effective concentration for 50% inhibition (EC50) of about 36 nM. They also inhibited infection of the laboratory-adapted HIV-1 strain NL4-3 with EC50 of about 4–5 nM, and against 47 HIV-1 clinical isolates circulating in China with mean EC50 of PEG2kC34 and PEG5kC34 of about 26 nM and 32 nM, respectively. The plasma half-life (t1/2) of PEG2kC34 and PEG5kC34 was 2.6 h and 5.1 h, respectively, and the t1/2 of PEGylated C34 was about 2.4-fold and 4.6-fold longer than C34 (~1.1 h), respectively. These findings suggest that PEGylated C34 with broad-spectrum anti-HIV-1 activity and prolonged half-life can be further developed as a peptide fusion inhibitor-based long-acting anti-HIV drug for clinical use to treat HIV-infected patients who have failed to respond to current anti-retrovirus drugs.

1 March 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
YZYuanyuan Zhang
Yuanyuan Zhang
QYQianqian Yin
Qianqian Yin
MNMing Ni
Ming Ni
TLTingting Liu
Tingting Liu
CWChen Wang
Chen Wang
LMLiying Ma
Liying Ma
Human immunodeficiency virus (HIV) quasispecies diversity presents a large barrier to the eradication of HIV. The aim of this study was to investigate intrahost HIV quasispecies diversity and evolutionary patterns underpinning the mechanisms of viral pathogenesis during antiretroviral therapy (ART). Forty-five participants with HIV-1 infection were enrolled in a follow-up cohort for >84 months in 2004, and received a lamivudine-based first-line ART regimen. Blood samples were collected every 6 months to measure viral load and CD4+ cell count. Ultra-deep sequencing and phylogenetic analysis were used to characterize the dynamics governing quasispecies diversity of HIV-1 circulating between plasma RNA and cellular DNA of participants with treatment failure (TF, n = 20) or virologic suppression (VS, n = 25). Analysis of the distribution of intrahost single-nucleotide variations (iSNVs) and their mutated allele frequencies revealed that approximately 65% of the quasispecies co-occurred in plasma HIV RNA and cellular DNA either before or after ART. The number and frequency of iSNVs are more representative of intrahost HIV diversity, and have better generalizability than phylogenetic inference by measurement of phylogenetic associations. Furthermore, drug-resistance-associated mutations (DRAMs) accumulated to high levels, dramatically increasing the DRAM-to-total-mutation ratio for TF patients. Linear regression analysis revealed that emergent mutations accumulated faster in TF patients compared with VS patients, at a rate of 0.02 mutations/day/kb. Based on iSNV analysis, the results demonstrate the dynamics of intrahost HIV quasispecies diversity in patients on ART, and provide a novel insight into the persistence of HIV and development of DRAMs.

16 December 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
YJYang Jiao
Yang Jiao
SLShuming Li
Shuming Li
ZLZhenpeng Li
Zhenpeng Li
ZZZheng Zhang
Zheng Zhang
JZJianhong Zhao
Jianhong Zhao
LMLiying Ma
Liying Ma
Transmitted drug resistance (TDR) is an important public health issue, because TDR-associated mutation may affect the outcome of antiretroviral treatment potentially or directly. Men who have sex with men (MSM) constitute a major risk group for HIV transmission. However, current reports are scarce on HIV TDR-associated mutations and their co-variation among MSM. Blood samples from 262 newly diagnosed HIV-positive, antiretroviral therapy (ART)-naïve MSM, were collected from January 2011 and December 2013 in Beijing. The polymerase viral genes were sequenced to explore TDR-associated mutations and mutation co-variation. A total of 223 samples were sequenced and analyzed. Among them, HIV-1 CRF01_AE are accounted for 60.5%, followed by CRF07_BC (27.8%), subtype B (9.9%), and others. Fifty-seven samples had at least one TDR-associated mutation, mainly including L10I/V (6.3%), A71L/T/V (6.3%), V179D/E (5.4%), and V106I (2.7%), with different distributions of TDR-associated mutations by different HIV-1 subtypes and by each year. Moreover, eight significant co-variation pairs were found between TDR-associated mutations (V179D/E) and seven overlapping polymorphisms in subtype CRF01_AE. To date, this work consists the most comprehensive genetic characterization of HIV-1 TDR-associated mutations prevalent among MSM. It provides important information for understanding TDR and viral evolution among Chinese MSM, a population currently at particularly high risk of HIV transmission.